Leishmaniasis in the Eastern Mediterranean Region

Eastern Mediterranean Health Journal

Volumn 2, Issue 1, 1996, Pages 94-101

  Neouimine, N I ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005758146     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Richard D et al. Identification and genetic comparison of leishmanial parasites causing viscerotropic and cutaneous disease in soldiers returning from Operation Desert Storm. American journal of tropical medicine and hygiene, 1993, 49(3):357-63.
2. El-Safi SH, Peters W. Studies on the leishmaniases in the Sudan. 1. Epidemic of cutaneous leishmaniasis in Khartoum. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1991, 85, 44-47.
3. Morsy TA et al. Rodents in relation to cutaneous leishmaniasis in north Sinai Governorate, Egypt. Journal of the Egyptian Society of Parasitology, 1987, 17(2):427-37.
4. Ben-Ismail R et al. Leishmaniasis, health services and epidemiology: avenues for a needed partnership. Parasitology today, 1994, 10(4):123.
5. El-Safi SH et al. Studies on the leishmaniases in the Sudan. 3. Clinical and parasitological studies on visceral and mucosal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1991, 85:469-70.
6. Leishmaniasis in southern Sudan. World health forum, 1993, 14:435.
7. Ben Rachid MS, Ben-Ismail R. Current situation in regard to leishmaniasis in Tunisia. Research on control strategies for the leishmaniases. Proceedings of an International Workshop held in Ottawa, Canada, 1-4 June 1987. IDRC.CRDI-CIID, Manuscript Report 184e.
8. Dowlati Y et al. A new candidate region for a Phase III leishmania vaccine trial using a different schedule (regimen). Synopses of presentations at a meeting on clinical trials of killed Leishmania major vaccine, Amman, Jordan, 15-16 April 1996.
9. Mansour NS et al. Cutaneous leishmaniasis in the peace keeping forces in east Sinai. Journal of the Egyptian Society of Parasitology, 1989, 19(2):725-31.
10. Hashim FA et al. An outbreak of acute kala-azar in a nomadic tribe in western Sudan: features of the disease in a previously non-immune population. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 88(4):431-2.
11. Zijlstra EE et al. Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1991, 85:365-9.
12. De Beer P et al. A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis. American journal of tropical medicine and hygiene, 1991, 44(3):283-9.
13. Ashford RW et al. Evidence for a long-term increase in the incidence of Leishmania tropica in Aleppo, Syria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993, 87(3):247-9.
14. Ashford RW et al. Cutaneous leishmaniasis in Kabul: observations on a "prolonged epidemic". Annals of tropical medicine and parasitology, 1992, 86(4):361-71.
15. Kadaro AY et al. Prevalence of cutaneous leishmaniasis along the Nile River north of Khartoum (Sudan) in the aftermath of an epidemic in 1985. American journal of tropical medicine and hygiene, 1993, 48(1):44-9.
16. Patz JA et al. Global climate change and emerging infectious diseases, Journal of the American Medical Association, 1996, 275(3):217-23.
17. Desjeux P. Human leishmaniases: epidemiology and public health aspects. World health statistics quarterly, 1992, 45(2/3):267-75.
18. Asilian A et al. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. American journal of tropical medicine and hygiene, 1995, 53(6):648-51.
19. Ben Salah A et al. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. American journal of tropical medicine and hygiene, 1995, 53(2):162-6.
20. El-Safi SH et al. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1990, 84:690-1.
21. Bahar K et al. Vaccine trial against zoonotic cutaneous leishmaniasis (Old World leishmaniasis) in Iran. Synopses of presentations at a meeting on clinical trials of killed Leishmania major vaccine. Amman, Jordan, 15-16 April 1996.
22. Chalib H et al. Killed Leishmania major (KLM) plus BCG vaccine in the protection against L. donovani infection in the Sudan. Synopses of presentations at a meeting on clinical trials of killed Leishmania major vaccine, Amman, Jordan, 15-16 April 1996.
23. Rab MA. Killed Leishmania major vaccine efficacy (Phase III) trial on non-immune adults in Baluchistan, Pakistan. Synopses of presentations ata meeting on clinical trials of killed Leishmania major vaccine, Amman, Jordan, 15-16 April 1996.
24. Kamhawi S et al. Environmental manipulation in the control of a zoonotic cutaneous leishmaniasis focus. Archives d'Institut Pasteur Tunis, 1993, 70(3-4):383-90.